Clinical Trial Update: A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study of LY2875358 in MET-positive, advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• LY2875358

Snippet

Sponsor: Eli Lilly and Company | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED